{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:32:55Z","timestamp":1760549575832},"reference-count":32,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T00:00:00Z","timestamp":1405987200000},"content-version":"vor","delay-in-days":4039,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study focused on the effects of tacalcitol (1,24(R)(OH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub>, TV\u201002) ointment (20 \u03bcg\/g) on cutaneous inflammation, epidermal proliferation, and differentiation and compared them with tacalcitol ointment (2 \u03bcg\/g) and other anti\u2010psoriatic ointments using hairless mice. Tacalcitol ointment (0, 2 and 20 \u03bcg\/g) significantly inhibited 12\u2010<jats:italic>O<\/jats:italic>\u2010tetradecanoylphorbol 13\u2010acetate (TPA)\u2010induced cutaneous inflammation, histopathologically. The effect of tacalcitol ointment (20 \u03bcg\/g) on cutaneous inflammation was much stronger than that of tacalcitol ointment (0, 2 \u03bcg\/g), and as effective as calcipotriol ointment (50 \u03bcg\/g) or betamethasone valerate ointment (1.2 mg\/g). Tacalcitol ointment (20 \u03bcg\/g) also significantly inhibited TPA\u2010induced myeloperoxidase (MPO) activity, as effectively as calcipotriol ointment (50 \u03bcg\/g) or betamethasone valerate ointment (1.2 mg\/g). The effect of tacalcitol ointment on epidermal proliferation [ornithine decarboxylase (ODC) activity] and differentiation [transglutaminase (TGase) activity] was dose\u2010dependent from 0 \u03bcg\/g to 20 \u03bcg\/g. The effect of tacalcitol ointments on epidermal proliferation was significant at the doses of 2 \u03bcg\/g and 20 \u03bcg\/g, and that on epidermal differentiation was significant at the doses of 0.2 \u03bcg\/g or more. The effect of tacalcitol ointment (20 \u03bcg\/g) on epidermal differentiation was significantly stronger than tacalcitol ointment (2 \u03bcg\/g). In this study, tacalcitol ointment (20 \u03bcg\/g) was found to have a marked effect on cutaneous inflammation and improved effect on epidermal differentiation, although tacalcitol ointment (2 \u03bcg\/g) also had significant effects on epidermal proliferation and differentiation. These findings support the clinical effectiveness of tacalcitol ointment (20 \u03bcg\/g) against psoriasis.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2003.tb00425.x","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T10:00:09Z","timestamp":1406023209000},"page":"510-524","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological Profiles of High\u2010Concentration (20 \u03bcg\/g) Tacalcitol Ointment: Effects on Cutaneous Inflammation, Epidermal Proliferation, and Differentiation in Mice"],"prefix":"10.1111","volume":"30","author":[{"given":"Hiroaki","family":"Sato","sequence":"first","affiliation":[{"name":"Pharmacological Research Department, Pharmaceuticals Development Research Laboratories Teijin Institute for Bio\u2010Medical Research  4\u20103\u20102 Asahigaoka Hino Tokyo 191\u20108512 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ogino","sequence":"additional","affiliation":[{"name":"Pharmacological Research Department, Pharmaceuticals Development Research Laboratories Teijin Institute for Bio\u2010Medical Research  4\u20103\u20102 Asahigaoka Hino Tokyo 191\u20108512 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Takagi","sequence":"additional","affiliation":[{"name":"Pharmacological Research Department, Pharmaceuticals Development Research Laboratories Teijin Institute for Bio\u2010Medical Research  4\u20103\u20102 Asahigaoka Hino Tokyo 191\u20108512 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Hata","sequence":"additional","affiliation":[{"name":"Safety Research Department, Pharmaceuticals Development Research Laboratories Teijin Institute for Bio\u2010Medical Research  4\u20103\u20102 Asahigaoka Hino Tokyo 191\u20108512 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Asano","sequence":"additional","affiliation":[{"name":"Safety Research Department, Pharmaceuticals Development Research Laboratories Teijin Institute for Bio\u2010Medical Research  4\u20103\u20102 Asahigaoka Hino Tokyo 191\u20108512 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Ohta","sequence":"additional","affiliation":[{"name":"Pharmacological Research Department, Pharmaceuticals Development Research Laboratories Teijin Institute for Bio\u2010Medical Research  4\u20103\u20102 Asahigaoka Hino Tokyo 191\u20108512 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Komoriya","sequence":"additional","affiliation":[{"name":"Pharmacological Research Department, Pharmaceuticals Development Research Laboratories Teijin Institute for Bio\u2010Medical Research  4\u20103\u20102 Asahigaoka Hino Tokyo 191\u20108512 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,22]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199754020-00005"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.64.105"},{"key":"e_1_2_5_4_1","first-page":"553","article-title":"High\u2010concentration (20 \u03bcg\/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids","volume":"12","author":"Katayama I","year":"2002","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_5_1","first-page":"463","article-title":"Long\u2010term safety and efficacy of high\u2010concentration (20 \u03bcg\/g) tacalcitol ointment in psoriasis vulgaris","volume":"12","author":"Miyachi Y","year":"2002","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246373"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02505274"},{"key":"e_1_2_5_8_1","first-page":"696","article-title":"Prostaglandin E\u2010mediated mitogenic stimulation of mouse epidermis in vivo by divalent cation ionophore A 23187 and by tumor promoter 12\u2010O\u2010tetradecanoylphorbol\u201013\u2010acetate","volume":"41","author":"Marks F","year":"1981","journal-title":"Cancer Res"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12280279"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/14.5.841"},{"key":"e_1_2_5_11_1","first-page":"51","volume-title":"Models in Dermatology","author":"McCullough JL","year":"1985"},{"key":"e_1_2_5_12_1","first-page":"1387","article-title":"Inhibition by 1\u03b1, 25\u2010dihydroxyvitamin D3 of induction of epidermal ornithine decarboxylase caused by 12\u2010O\u2010tetradecanoylphorbol 13\u2010acetate and teleocidin B","volume":"44","author":"Chida K","year":"1984","journal-title":"Cancer Res"},{"key":"e_1_2_5_13_1","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council, Institute of Laboratory Animal Resources","year":"1996"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12506462"},{"key":"e_1_2_5_15_1","first-page":"43","volume-title":"Worthington Enzyme Manual: Enzymes, Enzyme Reagents, Related Biochemicals","author":"Decker LA","year":"1972"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/45.3.290"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90217-X"},{"key":"e_1_2_5_18_1","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0021-9258(18)89608-9","article-title":"Retinoic acid\u2010induced transglutaminase in mouse epidermal cells is distinct from epidermal transglutaminase","volume":"260","author":"Lichti U","year":"1985","journal-title":"J Biol Chem"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199855010-00009"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1990.tb01614.x"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1990.tb03714.x"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701988"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02027.x"},{"key":"e_1_2_5_24_1","first-page":"106","article-title":"Tacalcitol inhibits epidermal inflammation and mast cell degranulation induced by TPA in mice","volume":"1","author":"Sato H","year":"1996","journal-title":"J Invest Dermatol"},{"key":"e_1_2_5_25_1","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.4049\/jimmunol.135.4.2279","article-title":"The effects of 1,25\u2010dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: A cell cycle analysis","volume":"135","author":"Rigby WF","year":"1985","journal-title":"J Immunol"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6427926"},{"key":"e_1_2_5_27_1","first-page":"s292","article-title":"Comparison of the effects of 22\u2010oxa\u20101,25 (OH)2D3 and MC\u2010903 on the production of IL\u20106, \u03b3\u2010IFN and lymphocyte proliferation in peripheral blood mononuclear cells","volume":"6","author":"Hustmyer FG","year":"1991","journal-title":"J Bone Miner Res"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240490106"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb00565.x"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb08035.x"},{"key":"e_1_2_5_31_1","first-page":"2368","article-title":"Association of hypercalcemia with tumors producing colony\u2010stimulating factor (s)","volume":"43","author":"Kondo Y","year":"1983","journal-title":"Cancer Res"},{"key":"e_1_2_5_32_1","first-page":"255","article-title":"Topical 1\u03b1,24(R)\u2010dihydroxyvitamin D3 for the treatment of psoriasis, Review of the literature","volume":"3","author":"Nishimura M","year":"1993","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1996.tb00157.x"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2003.tb00425.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2003.tb00425.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T18:10:00Z","timestamp":1700244600000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2003.tb00425.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1111\/j.1346-8138.2003.tb00425.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2003.tb00425.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}